Series A - GeneMedicine
Investment Firm
Overview
GeneMedicine is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies.
Announced Date
May 01, 2019
Funding Type
Series A
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 IMM Investment |
Round Details and Background
GeneMedicine raised $15000000 on 2019-05-01 in Series A
GeneMedicine is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies.
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 01, 2019 |  Series A - GeneMedicine | 1 | - | 15.0M |
Recent Activity
There is no recent news or activity for this profile.